A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
City of Hope Medical Center
Mayo Clinic
DL Analytics
National Cancer Institute, Naples
Corcept Therapeutics
Memorial Sloan Kettering Cancer Center
Arsenal Biosciences, Inc.
Marengo Therapeutics, Inc.
Tongji Hospital
University of Utah